Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors

Background: Neoadjuvant anti-tumor activity of an alternating taxane- and anthracycline-based dose-dense regimen in patients with operable, noninflammatory large breast cancer was investigated. Objective: The objective is to study the rate of pathological complete response in patients with breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Medioni, Jacques, Huchon, Cyrille, Le Frere-Belda, Marie-Aude, Hofmann, Henri, Bats, Anne-Sophie, Eme, Denise, Andrieu, Jean-Marie, Oudard, Stéphane, Lecuru, Fabrice, Levy, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585987/
https://www.ncbi.nlm.nih.gov/pubmed/21679005
http://dx.doi.org/10.2165/11591210-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585987/
https://www.ncbi.nlm.nih.gov/pubmed/21679005
http://dx.doi.org/10.2165/11591210-000000000-00000

Ejemplares similares